Jonathan Sheena
Founder at NATERA, INC.
Net worth: 42 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew Rabinowitz | M | 51 |
MyOme, Inc.
 MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | 21 years |
| Stephen Chapman | M | 45 | 14 years | |
| Michael Brophy | M | 44 | 9 years | |
| Herm Rosenman | M | 76 | 10 years | |
| Daniel Rabinowitz | M | 55 | 20 years | |
| Olesya Anisimova | F | - | 9 years | |
| Paul Greenland | M | - | - | |
| Oren Schaedel | M | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | - |
| Solomon Moshkevich | M | - | 13 years | |
| Gail Marcus | M | 67 | 7 years | |
| Kate Im | F | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | - |
| Ruth Williams-Brinkley | F | 72 | 1 years | |
| Roy Baynes | M | 69 | 6 years | |
| Akash Kumar | M | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | - |
| Rowan Chapman | M | 53 | 5 years | |
| Roelof Botha | M | 50 | 17 years | |
| James Healy | M | 58 | 10 years | |
| Eric S. Lander | M | 67 |
Massachusetts Institute of Technology
| 34 years |
| Ramesh Hariharan | M | - | - | |
| Minetta Liu | M | - | 2 years | |
| John Fesko | M | - | 1 years | |
| Lesley Bogdanow | F | - | - | |
| Nancy L. Rose | M | 64 |
Massachusetts Institute of Technology
| 29 years |
| Phil Grinnell | M | - | 13 years | |
| Maria Zuber | M | 66 |
Massachusetts Institute of Technology
| 29 years |
| Eric Evans | M | - | 4 years | |
| Premal S. Shah | M | - |
MyOme, Inc.
MyOme, Inc. Medical SpecialtiesHealth Technology MyOme, Inc. is a clinical whole genome analysis platform company that helps families understand their risk for inherited diseases. Certified under the Clinical Laboratory Improvement Amendments (CLIA), MyOme is based in San Carlos, CA. The company is a leader in polygenic modeling and leverage the power of the whole genome for a lifetime of actionable insights. In 2017, a group of geneticists, clinicians, biologists, engineers, parents, daughters, and sons formed MyOme believing that everyone can benefit from their services. MyOme maintains internet-accessible web sites, interactive user interfaces, mobile applications, and application programming interfaces for healthcare providers to complete the test requisition form (TRF) on their health system's interface. The company's proactive health report includes 78 genes identified as medically actionable by the American College of Medical Genetics and Genomics, providing a more complete picture of disease risk through clinical grade whole genome sequencing (up to 30x) and analysis. The company was founded by Matthew Rabinowitz, Kate Im, Akash Kumar, and Oren Schaedel. The CEO is Premal S. Shah. | - |
| John Deutch | M | 85 |
Massachusetts Institute of Technology
| 34 years |
| Rishi Kacker | M | - | - | |
| Robert Schueren | M | 62 | 5 years | |
| Ram Sasisekharan | M | 58 |
Massachusetts Institute of Technology
| 28 years |
| John B. Vander Sande | M | 79 |
Massachusetts Institute of Technology
| 32 years |
| Alexey Aleshin | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew C. Singer | M | - |
Massachusetts Institute of Technology
| 9 years |
| Mohsin Ansari | M | - |
Massachusetts Institute of Technology
| 6 years |
| Tidhar Shalon | M | 59 |
Massachusetts Institute of Technology
| - |
| Michael Zhang | M | - |
Massachusetts Institute of Technology
| 11 years |
| Benjamin van Roy | M | - |
Massachusetts Institute of Technology
| 9 years |
| Ioannis Kymissis | M | - |
Massachusetts Institute of Technology
| 9 years |
| Tri Tran | M | - |
Massachusetts Institute of Technology
| 5 years |
| Craig Griffin | M | - |
Massachusetts Institute of Technology
| 5 years |
| Paul Carey Konigsberg | M | - |
Massachusetts Institute of Technology
| 4 years |
| Andy Wheeler | M | 45 |
Massachusetts Institute of Technology
| 5 years |
| Jonathan Paul Loflin | M | - |
Massachusetts Institute of Technology
| 5 years |
| Dong-Sik Kim | M | 54 |
Massachusetts Institute of Technology
| 2 years |
| Wesley Chan | M | - |
Massachusetts Institute of Technology
| 5 years |
| Paul Greenberg | M | - |
Massachusetts Institute of Technology
| 4 years |
| Eric Oliver | M | - |
Massachusetts Institute of Technology
| 7 years |
| Reza Abhari | M | 62 |
Massachusetts Institute of Technology
| 3 years |
| Dustin Byrne | M | - |
Massachusetts Institute of Technology
| 5 years |
| Hákon Guðbjartsson | M | - |
Massachusetts Institute of Technology
| 5 years |
| Tom Rikert | M | - |
Massachusetts Institute of Technology
| 5 years |
| Guo Zhong Xie | M | 64 |
Massachusetts Institute of Technology
| 4 years |
| Hatice Hale Özsoy Biyikli | F | 47 |
Massachusetts Institute of Technology
| 4 years |
| Warren Chou | M | - |
Massachusetts Institute of Technology
| 6 years |
| Sung-Hwan Shin | M | 61 |
Massachusetts Institute of Technology
| 7 years |
| Rob Burn | M | - |
Massachusetts Institute of Technology
| 5 years |
| Georgios Alexopoulos | M | - |
Massachusetts Institute of Technology
| 5 years |
| Alan Chhabra | M | - |
Massachusetts Institute of Technology
| 5 years |
| Kathy Chiu | F | - |
Massachusetts Institute of Technology
| 5 years |
| Ilya Lisansky | M | - |
Massachusetts Institute of Technology
| 4 years |
| Feng Li | M | 56 |
Massachusetts Institute of Technology
| 4 years |
| Alexandre Santos | M | - |
Massachusetts Institute of Technology
| 4 years |
| Michael Minnich | M | 52 |
Massachusetts Institute of Technology
| 4 years |
| David Quiram | M | 49 |
Massachusetts Institute of Technology
| 5 years |
| Ming-Hokng Maa | M | 48 |
Massachusetts Institute of Technology
| 5 years |
| Kenneth Lau | M | 46 |
Massachusetts Institute of Technology
| 4 years |
| Kareem Akhtar | M | - |
Massachusetts Institute of Technology
| 5 years |
| Scott A. Miller | M | - |
Massachusetts Institute of Technology
| 5 years |
| Michael A. Klug | M | - |
Massachusetts Institute of Technology
| 7 years |
| Christopher J. Neil | M | 58 |
Massachusetts Institute of Technology
| 6 years |
| Telis Dimitri Bertsekas | M | - |
Massachusetts Institute of Technology
| 7 years |
| Philippe Laffont | M | - |
Massachusetts Institute of Technology
| 6 years |
| Mike McElroy | M | - |
Massachusetts Institute of Technology
| 9 years |
| Jake Seid | M | - |
Massachusetts Institute of Technology
| 2 years |
| Gregory Lambrecht | M | - |
Massachusetts Institute of Technology
| 6 years |
| Matthias B. Jaffé | M | 50 |
Massachusetts Institute of Technology
| 3 years |
| Mihnea Moldoveanu | M | - |
Massachusetts Institute of Technology
| 5 years |
| Robert Poor | M | - |
Massachusetts Institute of Technology
| 6 years |
| Adnan Lawai | M | - |
Massachusetts Institute of Technology
| 7 years |
| Todd Cozzens | M | 67 | 11 years | |
| Evren Ünver | M | - |
Massachusetts Institute of Technology
| 5 years |
| Adrianna Ma | F | 50 |
Massachusetts Institute of Technology
| 5 years |
| Ayman Mahmoud Hindy | M | - |
Massachusetts Institute of Technology
| 4 years |
| Andra Bolotin | F | 61 |
Massachusetts Institute of Technology
| 2 years |
| Eve Phillips | F | - |
Massachusetts Institute of Technology
| 5 years |
| Mike Capelle | M | - |
Massachusetts Institute of Technology
| 2 years |
| Henry Chung | M | - |
Massachusetts Institute of Technology
| 5 years |
| Albert Wong | M | 61 |
Massachusetts Institute of Technology
| 3 years |
| Shane M. Farritor | M | - |
Massachusetts Institute of Technology
| 5 years |
| Vanu G. Bose | M | - |
Massachusetts Institute of Technology
| 5 years |
| Chantal Moore | F | - |
Massachusetts Institute of Technology
| 6 years |
| Yong Gang Ren | M | 59 |
Massachusetts Institute of Technology
| 5 years |
| Warren Chen | M | - |
Massachusetts Institute of Technology
| 4 years |
| Maria Staton | F | 54 |
Massachusetts Institute of Technology
| 2 years |
| Katie Hall | M | - |
Massachusetts Institute of Technology
| 9 years |
| James L. McGrath | M | - |
Massachusetts Institute of Technology
| 5 years |
| Thilo Semmelbauer | M | 58 |
Massachusetts Institute of Technology
| 2 years |
| Tian Hang Hu | M | 46 |
Massachusetts Institute of Technology
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan Sheena
- Personal Network
